Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

Hu X, Hong K, Zhao C, Zheng Y, Ma L, Ruan Y, Gao H, Greene K, Sarzotti-Kelsoe M, Montefiori DC, Shao Y.

J Gen Virol. 2012 Oct;93(Pt 10):2267-78. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.

PMID:
22791603
2.

CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.

Sapsutthipas S, Tsuchiya N, Pathipavanich P, Ariyoshi K, Sawanpanyalert P, Takeda N, Isarangkura-na-ayuthaya P, Kameoka M.

PLoS One. 2013;8(1):e53920. doi: 10.1371/journal.pone.0053920. Epub 2013 Jan 7.

3.

Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.

OuYang Y, Sun J, Huang Y, Lu L, Xu W, Hu X, Hong K, Jiang S, Shao Y, Ma L.

Virol J. 2013 Jan 5;10:10. doi: 10.1186/1743-422X-10-10.

4.

Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).

Bao MJ, Geng WQ, Cui HL, Zhang XL, Xu DB, Nian H, Dai D, Wang YN, Shang H.

Mol Med Rep. 2012 May;5(5):1311-7. doi: 10.3892/mmr.2012.790. Epub 2012 Feb 14.

PMID:
22344547
5.

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

Hraber P, Korber BT, Lapedes AS, Bailer RT, Seaman MS, Gao H, Greene KM, McCutchan F, Williamson C, Kim JH, Tovanabutra S, Hahn BH, Swanstrom R, Thomson MM, Gao F, Harris L, Giorgi E, Hengartner N, Bhattacharya T, Mascola JR, Montefiori DC.

J Virol. 2014 Nov;88(21):12623-43. doi: 10.1128/JVI.01705-14. Epub 2014 Aug 20.

7.

Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.

Wang S, Nie J, Wang Y.

Virus Res. 2011 Jan;155(1):137-46. doi: 10.1016/j.virusres.2010.09.012. Epub 2010 Sep 25.

PMID:
20875470
8.

Similar neutralizing activity in the HIV-1 infected long term non-progressors(LTNPs) and typical progressors(TPs).

Wang Z, Li TY, Li JY, Chen LL, Liu YJ, Li HP, Bao ZY, Wang XL, Zhuang DM, Liu SY, Li L.

Virol Sin. 2012 Jun;27(3):165-71. doi: 10.1007/s12250-012-3239-8. Epub 2012 Jun 9.

PMID:
22684470
9.

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India.

Andrabi R, Bala M, Kumar R, Wig N, Hazarika A, Luthra K.

PLoS One. 2012;7(8):e43704. doi: 10.1371/journal.pone.0043704. Epub 2012 Aug 31.

10.

Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy.

Andrabi R, Makhdoomi MA, Kumar R, Bala M, Parray H, Gupta A, Kotnala A, Thirumurthy V, Luthra K.

J Clin Immunol. 2014 May;34(4):504-13. doi: 10.1007/s10875-014-0010-y. Epub 2014 Mar 29.

PMID:
24682667
11.

Serum neutralizing activities from a Beijing homosexual male cohort infected with different subtypes of HIV-1 in China.

Zhang M, Jiao Y, Wang S, Zhang L, Huang Z, Chen Y, Wu H.

PLoS One. 2012;7(10):e47548. doi: 10.1371/journal.pone.0047548. Epub 2012 Oct 18.

12.

Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China.

Chong H, Hong K, Zhang C, Nie J, Song A, Kong W, Wang Y.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):535-43. doi: 10.1097/QAI.0b013e3181663967.

PMID:
18209676
13.

Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India.

Prakash SS, Andrabi R, Kumar R, Lodha R, Kabra SK, Vajpayee M, Luthra K.

Arch Virol. 2012 Sep;157(9):1797-801. doi: 10.1007/s00705-012-1357-0. Epub 2012 Jun 7.

PMID:
22674340
14.

Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations.

Ferreira CB, Merino-Mansilla A, Llano A, Pérez I, Crespo I, Llinas L, Garcia F, Gatell JM, Yuste E, Sanchez-Merino V.

J Virol. 2013 Nov;87(22):12227-36. doi: 10.1128/JVI.02155-13. Epub 2013 Sep 4.

15.

The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, Tumba NL, Werner L, Mlisana K, Sibeko S, Williamson C, Abdool Karim SS, Morris L; CAPRISA002 Study Team..

J Virol. 2011 May;85(10):4828-40. doi: 10.1128/JVI.00198-11. Epub 2011 Mar 9.

16.

Epitope specificity of cross-clade neutralizing sera from Chinese HIV-1-positive individuals.

Song H, Chu Y, Zhang H, Wang X, Zhang T, Qiu M, Wu H, Wu Z.

Scand J Immunol. 2013 Oct;78(4):357-70. doi: 10.1111/sji.12091.

17.

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.

Marcelino JM, Borrego P, Nilsson C, Família C, Barroso H, Maltez F, Doroana M, Antunes F, Quintas A, Taveira N.

AIDS. 2012 Nov 28;26(18):2275-84. doi: 10.1097/QAD.0b013e328359a89d.

PMID:
23151495
18.

Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.

Medina-Ramírez M, Sánchez-Merino V, Sánchez-Palomino S, Merino-Mansilla A, Ferreira CB, Pérez I, González N, Alvarez A, Alcocer-González JM, García F, Gatell JM, Alcamí J, Yuste E.

J Virol. 2011 Jun;85(12):5804-13. doi: 10.1128/JVI.02482-10. Epub 2011 Apr 6.

19.

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.

Doria-Rose NA, Bhiman JN, Roark RS, Schramm CA, Gorman J, Chuang GY, Pancera M, Cale EM, Ernandes MJ, Louder MK, Asokan M, Bailer RT, Druz A, Fraschilla IR, Garrett NJ, Jarosinski M, Lynch RM, McKee K, O'Dell S, Pegu A, Schmidt SD, Staupe RP, Sutton MS, Wang K, Wibmer CK, Haynes BF, Abdool-Karim S, Shapiro L, Kwong PD, Moore PL, Morris L, Mascola JR.

J Virol. 2015 Oct 14;90(1):76-91. doi: 10.1128/JVI.01791-15.

20.

Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.

Kong R, Li H, Bibollet-Ruche F, Decker JM, Zheng NN, Gottlieb GS, Kiviat NB, Sow PS, Georgiev I, Hahn BH, Kwong PD, Robinson JE, Shaw GM.

J Virol. 2012 Jan;86(2):947-60. doi: 10.1128/JVI.06155-11. Epub 2011 Oct 26.

Supplemental Content

Support Center